Literature DB >> 11099095

Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient.

R Arav-Boger1, M Echavarria, M Forman, P Charache, D Persaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11099095     DOI： 10.1097/00006454-200011000-00016

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

Review 1.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 2.  Treatment of adenovirus infections in the immunocompromised host.

Authors:  P Ljungman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-10       Impact factor: 3.267

3.  A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.

Authors:  Kirsten Marie Williams; Allison L Agwu; Alix A Dabb; Meghan A Higman; David M Loeb; Alexandra Valsamakis; Allen R Chen
Journal:  J Pediatr Hematol Oncol       Date:  2009-11       Impact factor: 1.289

Review 4.  Fulminant hepatitis due to human adenovirus.

Authors:  B A Ronan; N Agrwal; E J Carey; G De Petris; S Kusne; M T Seville; J E Blair; H R Vikram
Journal:  Infection       Date:  2013-08-24       Impact factor: 3.553

Review 5.  Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.

Authors:  Joseph P Lynch; Adriana E Kajon
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 6.  Use of ribavirin in viruses other than hepatitis C. A review of the evidence.

Authors:  German Ramírez-Olivencia; Miriam Estébanez; Francisco Javier Membrillo; Maria Del Carmen Ybarra
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2018-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.